Does the new hair loss drug work outside the lab?
NCT ID NCT07226531
Summary
This study aims to see how well the medication ritlecitinib works for people with severe alopecia areata (an autoimmune condition causing hair loss) in real-world medical settings. It will look back at the medical records of about 300 people in the U.S. who were prescribed this drug to understand who uses it and what their hair regrowth results are. The goal is to learn how effective the treatment is in everyday practice, not just in controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.